A major mechanism of mRNA decay in yeast is initiated by deadenylation, fol
lowed by mRNA decapping, which exposes the transcript to 5' to 3' exonucleo
lytic degradation. The decapping enzyme that removes the 5' cap structure i
s encoded by the DCP1 gene. To understand the function of the decapping enz
yme, we used alanine scanning mutagenesis to create 31 mutant versions of t
he enzyme, and we examined the effects of the mutations both in vivo and in
vitro. Two types of mutations that affected mRNA decapping in vivo were id
entified, including a temperature-sensitive allele, First, two mutants prod
uced decapping enzymes that were defective for decapping in vitro, suggesti
ng that these mutated residues are required for enzymatic activity. In cont
rast, several mutants that moderately affected mRNA decapping in vivo yield
ed decapping enzymes that had at least the same specific activity as the wi
ld-type enzyme in vitro. Combination of alleles within this group yielded d
ecapping enzymes that showed a strong loss of function in vivo but that sti
ll produced fully active enzymes in vitro. This suggested that interactions
of the decapping enzyme with other factors may be required for efficient d
ecapping in vivo, and that these particular mutations may be disrupting suc
h interactions, Interestingly, partial loss of decapping activity in vivo l
ed to a defect in normal deadenylation-dependent decapping, but it did not
affect the rapid deadenylation-independent decapping triggered by early non
sense codons. This observation suggested that these two types of mRNA decap
ping differ in their requirements for the decapping enzyme.